MyMD Pharmaceuticals Analysis
| MYMDDelisted Stock | USD 1.82 0.02 1.09% |
MyMD Pharmaceuticals is overvalued with Real Value of 1.69 and Hype Value of 1.82. The main objective of MyMD Pharmaceuticals delisted stock analysis is to determine its intrinsic value, which is an estimate of what MyMD Pharmaceuticals is worth, separate from its market price. There are two main types of MyMD Pharmaceuticals' stock analysis: fundamental analysis and technical analysis.
The MyMD Pharmaceuticals stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and MyMD Pharmaceuticals' ongoing operational relationships across important fundamental and technical indicators.
MyMD |
MyMD Stock Analysis Notes
The company has price-to-book ratio of 0.46. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. MyMD Pharmaceuticals recorded a loss per share of 9.27. The entity last dividend was issued on the 25th of November 2019. The firm had 1:30 split on the 15th of February 2024. MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company was founded in 2014 and is headquartered in Baltimore, Maryland. Mymd Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 9 people. To find out more about MyMD Pharmaceuticals contact the company at (856) 848-8698 or learn more at https://www.mymd.com.MyMD Pharmaceuticals Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. MyMD Pharmaceuticals' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding MyMD Pharmaceuticals or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| MyMD Pharmaceuticals is now traded under the symbol TNFA. Please update your portfolios or report it if you believe this is an error. Report It! | |
| MyMD Pharmaceuticals is not yet fully synchronised with the market data | |
| MyMD Pharmaceuticals may become a speculative penny stock | |
| MyMD Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (4 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| MyMD Pharmaceuticals currently holds about 5.62 M in cash with (12.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.15. |
MyMD Pharmaceuticals Upcoming and Recent Events
| 29th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
MyMD Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.31 M.MyMD Pharmaceuticals Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific MyMD Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on MyMD Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases MyMD Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
MyMD Pharmaceuticals Outstanding Bonds
MyMD Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. MyMD Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most MyMD bonds can be classified according to their maturity, which is the date when MyMD Pharmaceuticals has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| MYLAN N V Corp BondUS62854AAP93 | View | |
| MYLAN N V Corp BondUS62854AAN46 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View |
MyMD Pharmaceuticals Predictive Daily Indicators
MyMD Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of MyMD Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About MyMD Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how MyMD Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling MyMD shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as MyMD Pharmaceuticals. By using and applying MyMD Stock analysis, traders can create a robust methodology for identifying MyMD entry and exit points for their positions.
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company was founded in 2014 and is headquartered in Baltimore, Maryland. Mymd Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 9 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding MyMD Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Pattern Recognition Now
Pattern RecognitionUse different Pattern Recognition models to time the market across multiple global exchanges |
| All Next | Launch Module |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in MyMD Stock
If you are still planning to invest in MyMD Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MyMD Pharmaceuticals' history and understand the potential risks before investing.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |